It is known that elevated inflammation through secretion of inflammatory mediators, such as interleukin (IL)-6, IL-8, IL-1β, tumor necrosis factor (TNF)-α and activation of nuclear factor (NF)-κB promotes the occurrence and development of NAFLD [7]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.